Farwell et al. [42] confirmed the previous results and although the study was not designed to correlate the tumor uptake with response therapy, they evaluated CD8 PET scans after the initiation of immunotherapy in 3 patients with a good response to therapy at the clinical follow-up. Here, CD8A is linked to neoplasm.